Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1989 2
1991 2
1992 4
1993 7
1994 11
1995 8
1996 4
1997 6
1998 7
1999 12
2000 13
2001 22
2002 23
2003 22
2004 22
2005 47
2006 54
2007 55
2008 49
2009 73
2010 67
2011 89
2012 83
2013 145
2014 152
2015 190
2016 162
2017 177
2018 217
2019 229
2020 316
2021 345
2022 336
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

2,677 results
Results by year
Filters applied: . Clear all
Page 1
Cuproptosis: copper-induced regulated cell death.
Duan WJ, He RR. Duan WJ, et al. Sci China Life Sci. 2022 Aug;65(8):1680-1682. doi: 10.1007/s11427-022-2106-6. Epub 2022 Apr 24. Sci China Life Sci. 2022. PMID: 35925445 No abstract available.
Radiomics in Nasopharyngeal Carcinoma.
Duan W, Xiong B, Tian T, Zou X, He Z, Zhang L. Duan W, et al. Clin Med Insights Oncol. 2022 Feb 24;16:11795549221079186. doi: 10.1177/11795549221079186. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35237090 Free PMC article. Review.
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
Ferrante M, Feagan BG, Panés J, Baert F, Louis E, Dewit O, Kaser A, Duan WR, Pang Y, Lee WJ, Gustafson D, Liao X, Wallace K, Kalabic J, D'Haens GR. Ferrante M, et al. Among authors: duan wr. J Crohns Colitis. 2021 Dec 18;15(12):2001-2010. doi: 10.1093/ecco-jcc/jjab093. J Crohns Colitis. 2021. PMID: 34077509 Free PMC article. Clinical Trial.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G. Ferrante M, et al. Among authors: duan wr. Lancet. 2022 May 28;399(10340):2031-2046. doi: 10.1016/S0140-6736(22)00466-4. Lancet. 2022. PMID: 35644155 Clinical Trial.
2D materials: Rising star for future applications.
Zou X, Xu Y, Duan W. Zou X, et al. Among authors: duan w. Innovation (Camb). 2021 May 4;2(2):100115. doi: 10.1016/j.xinn.2021.100115. eCollection 2021 May 28. Innovation (Camb). 2021. PMID: 34557763 Free PMC article. No abstract available.
2,677 results